WO2024083954A1 - A method of processing spent brewer's yeast - Google Patents
A method of processing spent brewer's yeast Download PDFInfo
- Publication number
- WO2024083954A1 WO2024083954A1 PCT/EP2023/079071 EP2023079071W WO2024083954A1 WO 2024083954 A1 WO2024083954 A1 WO 2024083954A1 EP 2023079071 W EP2023079071 W EP 2023079071W WO 2024083954 A1 WO2024083954 A1 WO 2024083954A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bsy
- autolysed
- lactic acid
- fermented
- fermentation
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 149
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 149
- 238000000034 method Methods 0.000 title claims abstract description 60
- 238000012545 processing Methods 0.000 title claims abstract description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 62
- 238000000855 fermentation Methods 0.000 claims abstract description 48
- 230000004151 fermentation Effects 0.000 claims abstract description 48
- 239000004310 lactic acid Substances 0.000 claims abstract description 31
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 31
- 208000035404 Autolysis Diseases 0.000 claims abstract description 19
- 206010057248 Cell death Diseases 0.000 claims abstract description 19
- 230000028043 self proteolysis Effects 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019658 bitter taste Nutrition 0.000 claims abstract description 10
- 241000894006 Bacteria Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 241000186713 Lactobacillus amylovorus Species 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 5
- 210000005253 yeast cell Anatomy 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- 235000021309 simple sugar Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 25
- 108090000623 proteins and genes Proteins 0.000 abstract description 25
- 239000004615 ingredient Substances 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000000835 fiber Substances 0.000 abstract description 6
- 235000013361 beverage Nutrition 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 5
- 235000013325 dietary fiber Nutrition 0.000 abstract description 4
- 230000001953 sensory effect Effects 0.000 abstract description 4
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 22
- 239000000047 product Substances 0.000 description 19
- 229920001503 Glucan Polymers 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 15
- 238000005187 foaming Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000006260 foam Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000013405 beer Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000019624 protein content Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 238000012193 PureLink RNA Mini Kit Methods 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000001146 hypoxic effect Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- UNYNVICDCJHOPO-UHFFFAOYSA-N sotolone Chemical compound CC1OC(=O)C(O)=C1C UNYNVICDCJHOPO-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- CLUWOWRTHNNBBU-UHFFFAOYSA-N 3-methylthiopropanal Chemical compound CSCCC=O CLUWOWRTHNNBBU-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001468192 Leuconostoc citreum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002387 Phytoglycogen Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 150000004652 butanoic acids Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical class CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 102220163706 rs886047595 Human genes 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
- C12N1/063—Lysis of microorganisms of yeast
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Definitions
- the present invention relates to a method of processing spent brewer’s yeast, and a spent brewer’s yeast product obtained by the method
- Spent yeast biomass is the second most plentiful by-product of the brewing industry, with approximately 15-18 tons of surplus yeast produced per 10,000 hL of beer.
- Brewer’s spent yeast (BSY) serves well as an inexpensive source of protein, fibre vitamins, and minerals. With an increasing global interest in sustainability, the upcycling of waste materials for reuse is gaining momentum. However, due to its extremely bitter taste, there are very few outlets for BSY.
- the current primary use of brewer’s spent yeast is in formulations for animal and fish feed, where it has been shown to induce positive effects, including increased milk yield, improved pathogen resistance, and improved general health. Efforts have been made to debitter spent yeast but often require toxic alkali treatments, which is not ideal if the material is intended for food applications. Physical separation by means of rotary microfiltration has also been explored but was found to be not as effective as the alkaline washing methods.
- Several methods of decreasing RNA content have been explored, comprising of chemical and autolytic methods, though few have been applied to spent yeast.
- the use of membrane separation technology to significantly reduce RNA content in spent yeast has been described. The reduction of RNA through processing technologies could allow for an increased volume of the processed BSY to be consumed more regularly, optimising the nutritional benefits of the BSY.
- the Applicant has addressed the problems of the prior by providing a method of processing that allows BSY to be transformed into a pleasant tasting, nutritious and functional ingredient which enables the ingredient to be used for human consumption.
- the process developed comprises autolysis of the BSY followed by lactic acid fermentation and optionally drying.
- the process reduces the bitterness drastically, reduces RNA and alcohol significantly, and changes the sensory profile as well as the techno-functional properties of the fermented BSY.
- the resultant fermented BSY product is very high in protein and valuable dietary fibre and therefore follows the current trend to increase the intake of plant and mycoproteins and fibre. Since the fermented BSY is produced from a waste stream of the brewing industry, it would be regarded as a sustainable process
- a method of processing spent brewer’s yeast comprising the steps of: autolysis of the BSY; and lactic fermentation of the autolysed BSY (typically with a lactic acid bacterium (LAB)) to provide a fermented BSY product.
- BSY spent brewer’s yeast
- the step of lactic fermentation comprises incubating in a reactor vessel a fermentation mixture comprising autolysed BSY and a fermenting bacterium, typically a lactic acid bacterium.
- the fermentation mixture comprises autolysed BSY, a fermenting bacterium, and a sugar.
- the fermentation mixture consists essentially of autolysed BSY, a fermenting bacterium, and a sugar.
- the autolysed BSY makes up at least 60%, 70%, 80%, 90%, or 95% (w/v) of the fermentation mixture.
- the fermented BSY product is dried.
- drying is performed by freeze-drying or spray drying.
- Other drying methods such as vacuum drying and rotary evaporation may also be applied.
- the fermented BSY product is pasteurised prior to drying.
- a carbon source is added to the BSY.
- the carbon source is added prior to autolysis.
- the carbon source is a simple sugar, such as sucrose, glucose or fructose. In any embodiment, the carbon source is added at 1-10%, 2-6%, 3-5% or about 4% (w/w).
- the LAB is an alcohol tolerant strain of LAB.
- the LAB is capable of growing in BSY having an alcohol content of up to 10% or 9%, and typically at least 3%, 4%, 5%, 6%, 7% or 8% (v/v).
- the LAB is a strain of Lactobacillus amylovorus.
- the strain of Lactobacillus amylovorus is Lactobacillus amylovorus FST 2.11 .
- Lactobacillus amylovorus designated FST 2.11 is deposited under the accession no DSM 19280 on 13th Apr. 2007 at the DSMZ (Deutsche Sammlung von
- the autolysis step comprises thermal autolysis of the BSY.
- the thermal autolysis comprises heating the BSY at for a time and temperature suitable to degrade yeast RNA, optionally followed by sterilisation to kill any viable yeast cells prior to the fermentation.
- the heating step comprises heating the BSY at 40-60°C for 12- 48h.
- the sterilisation step comprises sterilising the heated BSY at 80-100°C for 20-40 minutes.
- the sterilisation step comprises sterilising the heated BSY at 85-95°C for 25-35 minutes.
- the autolysis step comprises enzymatic autolysis.
- the BSY is treated to reduce the alcohol content, optionally by centrifugation.
- Other dewatering methods may be employed such as a filtration technology.
- the solids content of the alcohol depleted BSY is normalised by adding water.
- the solids content of the BSY is normalised to 10 to 60%, preferably about 20 to 60%, (w/v).
- the solids content of the BSY is normalised to 30 to 50% (w/v).
- the solids content of the BSY is normalised to 35 to 45% (w/v).
- the invention provides an autolysed and lactic acid fermented BSY product.
- the autolysed and lactic acid fermented BSY product is a food ingredient (e.g., for use in foods or beverages).
- the fermented BSY product is obtained by a method of the invention.
- the fermented BSY product has a bitterness lower than BSY that has not been autolysed and subjected to lactic acid fermentation.
- the fermented BSY product comprises less than 129, 110 or 105 IBU mg/ L of bitterness compounds ((iso-a-acids) as determined using the method described below.
- the fermented BSY product has a RNA content lower than BSY that has not been autolysed and subjected to lactic acid fermentation.
- the fermented BSY product has a RNA content of less than 2%, 1 .5% or 1 .2% (w/w) as determined using the method described below.
- the fermented BSY product has a protein content that is at least 95% (w/w) of BSY that has not been autolysed and subjected to lactic acid fermentation.
- the fermented BSY product has a protein content of 25 to 40 % (w/w) as determined using the method described below.
- the fermented BSY product has an energy content of at least 250, 270, 280 or 290 kCal as determined using the method described below.
- the fermented BSY product has a free amino acid content of 5 to 15 g/100 g.as determined using the method described below.
- the invention provides a food or beverage comprising the fermented BSY product of the invention.
- the invention relates to the use of the BSY product of the invention as an ingredient for foods or beverages, for example as a flavouring agent in a food or beverage product.
- Figure 1 A schematic illustration of one embodiment of the method of the invention.
- Figure 2 Free Amino Acid composition of CBSY and PBSY, expressed as g/100 g.
- Figure 3 Comparison of aroma, taste, and flavour characteristics, plotted using the mean intensity rating for CBSY (solid line) and PBSY (dashed line).
- FIG. 4 Colour Comparison of BSY ingredients; CBSY (Left) and PBSY (Right).
- Figure 5 The separation profiles of CBSY and PBSY emulsions, showing light transmission over the length of the sample with the top of the cell on the left and the bottom on the right.
- FIG. 6 Temperature sweep curve, showing the storage modulus (G’), the loss modulus (G”) and temperature. Curves are plotted using the average values of triplicate data.
- Figure 7 Tan 6 values for CBSY and PBSY, as a function of time, over the defined heating and cooling cycle.
- the term “comprise,” or variations thereof such as “comprises” or “comprising,” are to be read to indicate the inclusion of any recited integer (e.g. a feature, element, characteristic, property, method/process step or limitation) or group of integers (e.g. features, element, characteristics, properties, method/process steps or limitations) but not the exclusion of any other integer or group of integers.
- the term “comprising” is inclusive or open- ended and does not exclude additional, unrecited integers or method/process steps.
- Spent yeast was provided by commercial brewery and frozen at -20°C until required.
- the yeast provided was a 5th generation lager strain.
- Yeast was cropped after ⁇ 120-160 hours of fermentation (5-7 days).
- Lactobacillus amylovorus FST2.11 was originally isolated from a cereal environment (Arendt et al., 2009) and is part of the University College Cork culture collection.
- a wide range of lactic acid bacteria strains were screened for their performance in a BSY fermentation and used to optimise the fermentation process (data not shown) before L amylovorus FST2.11 was selected for use due to its superior performance.
- Frozen stock cultures were maintained at -80°C in 40% glycerol.
- the strain was routinely cultivated on deMan- Rogosa-Sharpe (MRS) agar supplemented with 0.05g/L bromocresol green and incubated anaerobically at 30°C for 48h.
- MRS deMan- Rogos
- the solids content of the BSY was standardised by centrifuging at 12,000 x g for 30 minutes, after which the supernatant was discarded, and sterile water was added to reach a solids content of 40%. 700ml aliquots of standardised BSY were placed into 1 L bioreactor vessels, to which 4% sucrose was added. Autolysis was performed at 50°C for 20h for degradation of yeast RNA, followed by sterilisation at 90°C for 30 minutes to kill any viable yeast cells prior to the fermentation.
- L amylovorus FST2.11 Working cultures of L amylovorus FST2.11 were prepared by inoculating single colonies into 10ml of MRS broth and incubating at 30°C for 24h, followed by subculturing (1 %) into fresh MRS broth for 18h. Cells were harvested by centrifugation at 5000 x g for 5 minutes, washed and resuspended in an equal volume of strength Ringer’s solution. After sterilisation, the BSY was cooled to 30°C and inoculated with 1 % washed L amylovorus FST2.11 cultures. Bioreactor fermentations were performed using a DASGIP Bioblock (Eppendorf, UK) for temperature and agitation control.
- BSY fermentations were carried out for 72 hours at 30°C with a stirring rate of 200 rpm. At the end of the fermentation period, the BSY was pasteurised at 72°C for 15 min (processed BSY; PBSY). BSY which did not undergo any standardisation or fermentation was pasteurised at 72°C for 15 min and included as a control (CBSY). PBSY and CBSY samples were frozen at -80°C and subsequently freeze-dried to produce a dried ingredient.
- the pH and TTA of the samples were determined according to a standardised method (AACC 02-31.01 ).
- Alcohol content (% v/v) was measured using an Alcolyzer beer analysing system consisting of a DMA 4500 M density meter, an Alcolyzer beer ME measuring module and an Xsample 520 sample changer (Anton Paar, GmbH, Graz, Austria).
- RNA was isolated from the samples using a PureLink RNA Mini Kit (ThermoFisher Scientific, Massachusetts, USA) and quantified using a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Massachusetts, USA)Cell counts of L.
- amylovorus FST2.11 were determined by diluting 1 ml aliquots of BSY in 9ml of strength Ringers’ solution. Samples were serially diluted and 10OpI aliquots were spread-plated onto MRS agar supplemented with 0.05g/L bromocresol green. Plates were incubated anaerobically at 30°C for 48h.
- the aroma, taste, and flavour characteristics of CBSY and FBSY were determined by a panel of seven experienced panel members.
- Sample preparation consisted of dissolving the CBSY and FBSY powders in water at a 5 % w/w concentration and labelling each with a three digit code to avoid bias.
- Characteristics included aroma, taste, flavour and aftertaste descriptors (Aroma; intensity, yeast, cereal/grain, beer, fruity, roasted. Taste; sour, bitter, sweet, umami, salty. Flavour; Intensity, mushroom, roasted, yeast, beer, cheese, fruity. Aftertaste; intensity).
- the colour of the ingredient powders was measured using the Minolta colour measuring system (Chroma meter CR-400/410 Konica Minolta). Colour was measured using the CIE colour system (XYZ values) and then translated into and reported using the hunter colour system (L*a*b*).
- the 1 ,3:1 ,6-[3-glucan and a-glucan content of the samples was determined using the Yeast and Mushroom [3-glucan assay kit (Megazyme, Bray, Ireland). This method consists of solubilising and hydrolysing all glucans ( 1 ,3:1 ,6-[3-D-Glucans,
- a-glucans i.e. phytoglycogen and starch
- sucrose are specifically hydrolysed using amyloglucosidase and invertase. [3-glucan is then determined by difference.
- Foaming Dispersions (20 mL in 50 mL centrifuge tubes) with a concentration of 2% were prepared using distilled water. The pH was adjusted to pH 7 for half of the samples using a variety of HCI and NaOH dilutions. Samples were allowed to hydrate overnight at 4°C. After allowing the samples to return to room temperature, pH was checked and re-adjusted if needed. The samples were then frothed using an llltra- Turrax equipped with a S10N-10G dispersing element (Ika-Labortechnik, Janke and Kunkel GmbH, Staufen, Germany) at maximum speed for 30 s. The height of the foam phase was recorded immediately and after 60 mins. Foaming capacity and foam stability were determined by the following:
- Foaming capacity (%) (Foam height immediately after foaming I Initial sample height) x 100
- Foam stability (%) (Foam height after 1 h I Foam height immediately after foaming) x 100
- the water and oil binding capacities of the CBSY and PBSY were determined according to the method of (Boye et al., 2010) with some slight modifications. 15 mL tubes were weighed, and the weight noted and then 1 g of sample was weighed into each tube. Then 6 g of either sunflower oil or water was added to the tubes and mixed well, via vortex, for 3 minutes. Samples were then kept at room temperature for 1 hour. Samples were then centrifuged at 4000 x g for 30 minutes at 20°C. Supernatant was removed and samples were inverted and allowed to drain for 30 minutes. The tubes were then re-weighed and the % oil or water absorption was calculated using the following:
- WHC/OHC (%) ((Weight of tube and pellet)-(Weight of tube)-(lnitial ingredient weight))/(lnitial ingredient weight) *100
- Protein solubility, at native and adjusted pH (pH 7) was evaluated using the Kjeldahl method. Firstly, the protein contents of CBSY and PBSY were determined. Following this, 1 % (w/v) protein dispersions were prepared and then left to hydrate over night at 4°C, while shaking. After returning to room temperature, pH was check ad re-adjusted if necessary. Samples were then centrifuged at maximum speed (4892 x g) for 30 mins. The protein content of the supernatant was determined, and protein solubility can be expressed as the % of total protein present in the supernatant.
- the surface acting properties of CBSY and PBSY were examined by creating and analysing rough emulsions using the method of (Horstmann et al., 2017) with some modifications.
- a 1 % w/w aqueous protein solution was prepared using CBSY/PBSY and adjusted to pH 7 using NaOH and HCI. Samples were then hydrated overnight, shaking, at 4°C. These solutions were then used to prepare a 10 % w/w sunflower oil/protein solution mixtures where were then homogenised for 2 minutes using an Ultraturrax T10, fitted with S10N - 10G dispersing tool, to create an emulsion.
- Particle size was then analysed using a Mastersizer 3000 (Malvern Instruments Ltd., Worcestershire, UK), using a refractive index of 1.47.
- Emulsion stability was analysed using a LUMisizer (L.U.M. GmbH, Germany), at 100 ref for 15 minutes.
- the temperature profile was defined as an increase from 20 °C to 90 °C, followed by a hold at 90 °C for 30 minutes, cooling to 20°C, and a hold at 20 °C for 30 minutes. This was followed by a frequency sweep from 0.01 Hz to 10 Hz, while maintaining 1 % strain.
- Table 5 Oil and Water absorption capacity of CBSY and PBSY, expressed as a percentage of initial sample weight
- Table 8 The surface hydrophobicity, protein solubility (%), and Zeta potential (mV) of CBSY and PBSY, at native pH and pH 7
- Protein Solubility (%) Native 31 .531 ⁇ 0.420 75.426 ⁇ 0.419 pH pH 7 31.508 ⁇ 0.331 72.916 ⁇ 0.174
- Fermentation with BSY significantly increases levels of free amino acids.
- the level of RNA in the food is decreased.
- the flavour and aroma are transformed from bitter, yeast-like and alcohol-like to a more pleasant fruity, sour and floral profile.
- the levels of lactic acid and pyruvic acid are increased, and pH is lowered from pH 6 to pH3.5.
- the colour changed from a pale, creamy beige to a warm, biscuit-like brown.
- Protein solubility increased significantly. Foaming capacity and stability are improved. Many important functional properties, such as gelling, fat absorption and emulsifying properties are unaffected by the process.
- the key nutritional profile is unchanged by processing.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A method of processing spent brewer's yeast (BSY) to a fermented BSY product is described. The BSY product is a pleasant tasting, nutritious and functional ingredient which enables the ingredient to be used for human consumption in foods and beverages. The method comprises autolysis of the BSY followed by lactic acid fermentation and optionally drying. The method reduces the bitterness drastically, removes RNA and alcohol significantly, and changes the sensory profile as well as the techno-functional properties of the fermented BSY. The resultant fermented BSY product is very high in protein and valuable dietary fibre and therefore follows the current trend to increase the intake of plant and mycoproteins and fibre.
Description
TITLE
A method of processing spent brewer’s yeast
Field of the Invention
The present invention relates to a method of processing spent brewer’s yeast, and a spent brewer’s yeast product obtained by the method
Background to the Invention
Spent yeast biomass is the second most plentiful by-product of the brewing industry, with approximately 15-18 tons of surplus yeast produced per 10,000 hL of beer. Brewer’s spent yeast (BSY) serves well as an inexpensive source of protein, fibre vitamins, and minerals. With an increasing global interest in sustainability, the upcycling of waste materials for reuse is gaining momentum. However, due to its extremely bitter taste, there are very few outlets for BSY. The current primary use of brewer’s spent yeast is in formulations for animal and fish feed, where it has been shown to induce positive effects, including increased milk yield, improved pathogen resistance, and improved general health. Efforts have been made to debitter spent yeast but often require toxic alkali treatments, which is not ideal if the material is intended for food applications. Physical separation by means of rotary microfiltration has also been explored but was found to be not as effective as the alkaline washing methods.
Another challenge facing the increased use of spent yeast in food products is the high proportion of RNA present in yeast cells. RNA degrades into purines and uric acid, which can cause health issues such as hyperuricemia and gout in large volumes. Generally, there is no issue if yeast ingredients are incorporated at low levels. However, there could be health risks if yeast is used as a significant source
of nutrition in the diet. Several methods of decreasing RNA content have been explored, comprising of chemical and autolytic methods, though few have been applied to spent yeast. The use of membrane separation technology to significantly reduce RNA content in spent yeast has been described. The reduction of RNA through processing technologies could allow for an increased volume of the processed BSY to be consumed more regularly, optimising the nutritional benefits of the BSY.
To date, applications for BSY are largely animal-feed based, and even in animal feed, the high bitterness, alcohol content, and susceptibility to spoilage can be challenging.
It is an object of the invention to overcome at least one of the above-referenced problems.
Summary of the Invention
The Applicant has addressed the problems of the prior by providing a method of processing that allows BSY to be transformed into a pleasant tasting, nutritious and functional ingredient which enables the ingredient to be used for human consumption. The process developed comprises autolysis of the BSY followed by lactic acid fermentation and optionally drying. The process reduces the bitterness drastically, reduces RNA and alcohol significantly, and changes the sensory profile as well as the techno-functional properties of the fermented BSY. The resultant fermented BSY product is very high in protein and valuable dietary fibre and therefore follows the current trend to increase the intake of plant and mycoproteins and fibre. Since the fermented BSY is produced from a waste stream of the brewing industry, it would be regarded as a sustainable process
In accordance with the first aspect of the invention there is provided a method of processing spent brewer’s yeast (BSY) comprising the steps of: autolysis of the BSY; and
lactic fermentation of the autolysed BSY (typically with a lactic acid bacterium (LAB)) to provide a fermented BSY product.
In any embodiment, the step of lactic fermentation comprises incubating in a reactor vessel a fermentation mixture comprising autolysed BSY and a fermenting bacterium, typically a lactic acid bacterium.
In any embodiment, the fermentation mixture comprises autolysed BSY, a fermenting bacterium, and a sugar.
In any embodiment, the fermentation mixture consists essentially of autolysed BSY, a fermenting bacterium, and a sugar.
In any embodiment, the autolysed BSY makes up at least 60%, 70%, 80%, 90%, or 95% (w/v) of the fermentation mixture.
In any embodiment, the fermented BSY product is dried.
In any embodiment, drying is performed by freeze-drying or spray drying. Other drying methods, such as vacuum drying and rotary evaporation may also be applied.
In any embodiment, the fermented BSY product is pasteurised prior to drying.
In any embodiment, a carbon source is added to the BSY.
In any embodiment, the carbon source is added prior to autolysis.
In any embodiment, the carbon source is a simple sugar, such as sucrose, glucose or fructose.
In any embodiment, the carbon source is added at 1-10%, 2-6%, 3-5% or about 4% (w/w).
In any embodiment, the LAB is an alcohol tolerant strain of LAB.
In any embodiment, the LAB is capable of growing in BSY having an alcohol content of up to 10% or 9%, and typically at least 3%, 4%, 5%, 6%, 7% or 8% (v/v).
In any embodiment, the LAB is a strain of Lactobacillus amylovorus.
In any embodiment, the strain of Lactobacillus amylovorus is Lactobacillus amylovorus FST 2.11 .
Lactobacillus amylovorus designated FST 2.11 is deposited under the accession no DSM 19280 on 13th Apr. 2007 at the DSMZ (Deutsche Sammlung von
Mikroorganismen and Zellkulturen). The invention is not restricted to this strain, and other L amylovorus strains, or indeed other lactobacillus strains showing antifungal activity and alcohol tolerance may be employed. Examples of other lactic acid bacteria that may be employed in the methods of the present invention include:
Lactobacillus plantarum FST 1.7
L paracasei FST 6.1
L brevis R2A
L rhamnosus LGG
Leuconostoc citreum TR116
L pseudomesenteroides MP070
Pediococcus pentosaceus YP1.7.1.1
In any embodiment, the autolysis step comprises thermal autolysis of the BSY.
In any embodiment, the thermal autolysis comprises heating the BSY at for a time and temperature suitable to degrade yeast RNA, optionally followed by sterilisation to kill any viable yeast cells prior to the fermentation.
In any embodiment, the heating step comprises heating the BSY at 40-60°C for 12- 48h.
In any embodiment, the sterilisation step comprises sterilising the heated BSY at 80-100°C for 20-40 minutes.
In any embodiment, the sterilisation step comprises sterilising the heated BSY at 85-95°C for 25-35 minutes.
In another embodiment, the autolysis step comprises enzymatic autolysis.
In any embodiment, generally prior to the autolysis step, the BSY is treated to reduce the alcohol content, optionally by centrifugation. Other dewatering methods may be employed such as a filtration technology.
In any embodiment, the solids content of the alcohol depleted BSY is normalised by adding water.
In any embodiment, the solids content of the BSY is normalised to 10 to 60%, preferably about 20 to 60%, (w/v).
In any embodiment, the solids content of the BSY is normalised to 30 to 50% (w/v).
In any embodiment, the solids content of the BSY is normalised to 35 to 45% (w/v).
In another aspect, the invention provides an autolysed and lactic acid fermented BSY product.
In any embodiment, the autolysed and lactic acid fermented BSY product is a food ingredient (e.g., for use in foods or beverages).
In another aspect, the fermented BSY product is obtained by a method of the invention.
In any embodiment, the fermented BSY product has a bitterness lower than BSY that has not been autolysed and subjected to lactic acid fermentation.
In any embodiment, the fermented BSY product comprises less than 129, 110 or 105 IBU mg/ L of bitterness compounds ((iso-a-acids) as determined using the method described below.
In any embodiment, the fermented BSY product has a RNA content lower than BSY that has not been autolysed and subjected to lactic acid fermentation.
In any embodiment, the fermented BSY product has a RNA content of less than 2%, 1 .5% or 1 .2% (w/w) as determined using the method described below.
In any embodiment, the fermented BSY product has a protein content that is at least 95% (w/w) of BSY that has not been autolysed and subjected to lactic acid fermentation.
In any embodiment, the fermented BSY product has a protein content of 25 to 40 % (w/w) as determined using the method described below.
In any embodiment, the fermented BSY product has an energy content of at least 250, 270, 280 or 290 kCal as determined using the method described below.
In any embodiment, the fermented BSY product has a free amino acid content of 5 to 15 g/100 g.as determined using the method described below.
In another aspect, the invention provides a food or beverage comprising the fermented BSY product of the invention.
In another aspect, the invention relates to the use of the BSY product of the invention as an ingredient for foods or beverages, for example as a flavouring agent in a food or beverage product.
Other aspects and preferred embodiments of the invention are defined and described in the other claims set out below.
Brief Description of the Figures
Figure 1 : A schematic illustration of one embodiment of the method of the invention.
Figure 2: Free Amino Acid composition of CBSY and PBSY, expressed as g/100 g.
Figure 3: Comparison of aroma, taste, and flavour characteristics, plotted using the mean intensity rating for CBSY (solid line) and PBSY (dashed line).
Figure 4: Colour Comparison of BSY ingredients; CBSY (Left) and PBSY (Right).
Figure 5: The separation profiles of CBSY and PBSY emulsions, showing light transmission over the length of the sample with the top of the cell on the left and the bottom on the right.
Figure 6: Temperature sweep curve, showing the storage modulus (G’), the loss modulus (G”) and temperature. Curves are plotted using the average values of triplicate data.
Figure 7: Tan 6 values for CBSY and PBSY, as a function of time, over the defined heating and cooling cycle.
Detailed Description of the Invention
All publications, patents, patent applications and other references mentioned herein are hereby incorporated by reference in their entireties for all purposes as if each individual publication, patent or patent application were specifically and individually indicated to be incorporated by reference and the content thereof recited in full.
Where used herein and unless specifically indicated otherwise, the following terms are intended to have the following meanings in addition to any broader (or narrower) meanings the terms might enjoy in the art:
Unless otherwise required by context, the use herein of the singular is to be read to include the plural and vice versa. The term "a" or "an" used in relation to an entity is to be read to refer to one or more of that entity. As such, the terms "a" (or "an"), "one or more," and "at least one" are used interchangeably herein.
As used herein, the term "comprise," or variations thereof such as "comprises" or "comprising," are to be read to indicate the inclusion of any recited integer (e.g. a feature, element, characteristic, property, method/process step or limitation) or group of integers (e.g. features, element, characteristics, properties, method/process steps or limitations) but not the exclusion of any other integer or group of integers. Thus, as used herein the term "comprising" is inclusive or open- ended and does not exclude additional, unrecited integers or method/process steps.
The invention will now be described with reference to specific Examples. These are merely exemplary and for illustrative purposes only: they are not intended to be limiting in any way to the scope of the monopoly claimed or to the invention
described. These examples constitute the best mode currently contemplated for practicing the invention.
Materials and Methods
Raw material and bacterial strain
Spent yeast was provided by commercial brewery and frozen at -20°C until required. The yeast provided was a 5th generation lager strain. Yeast was cropped after ~120-160 hours of fermentation (5-7 days). Lactobacillus amylovorus FST2.11 was originally isolated from a cereal environment (Arendt et al., 2009) and is part of the University College Cork culture collection. A wide range of lactic acid bacteria strains were screened for their performance in a BSY fermentation and used to optimise the fermentation process (data not shown) before L amylovorus FST2.11 was selected for use due to its superior performance. Frozen stock cultures were maintained at -80°C in 40% glycerol. The strain was routinely cultivated on deMan- Rogosa-Sharpe (MRS) agar supplemented with 0.05g/L bromocresol green and incubated anaerobically at 30°C for 48h.
BSY fermentation
Prior to fermentation, the solids content of the BSY was standardised by centrifuging at 12,000 x g for 30 minutes, after which the supernatant was discarded, and sterile water was added to reach a solids content of 40%. 700ml aliquots of standardised BSY were placed into 1 L bioreactor vessels, to which 4% sucrose was added. Autolysis was performed at 50°C for 20h for degradation of yeast RNA, followed by sterilisation at 90°C for 30 minutes to kill any viable yeast cells prior to the fermentation. Working cultures of L amylovorus FST2.11 were prepared by inoculating single colonies into 10ml of MRS broth and incubating at 30°C for 24h, followed by subculturing (1 %) into fresh MRS broth for 18h. Cells were harvested by centrifugation at 5000 x g for 5 minutes, washed and resuspended in an equal volume of strength Ringer’s solution. After sterilisation, the BSY was cooled to 30°C and inoculated with 1 % washed L amylovorus FST2.11 cultures. Bioreactor fermentations were performed using a DASGIP
Bioblock (Eppendorf, UK) for temperature and agitation control. BSY fermentations were carried out for 72 hours at 30°C with a stirring rate of 200 rpm. At the end of the fermentation period, the BSY was pasteurised at 72°C for 15 min (processed BSY; PBSY). BSY which did not undergo any standardisation or fermentation was pasteurised at 72°C for 15 min and included as a control (CBSY). PBSY and CBSY samples were frozen at -80°C and subsequently freeze-dried to produce a dried ingredient.
Characterisation of fermentation profiles
To monitor fermentation kinetics of FST 2.11 , samples were taken every 24h. The pH, TTA and microbial cell count were analysed.
2.3.1 pH, TTA, alcohol, and microbial growth determination
The pH and TTA of the samples were determined according to a standardised method (AACC 02-31.01 ). Alcohol content (% v/v) was measured using an Alcolyzer beer analysing system consisting of a DMA 4500 M density meter, an Alcolyzer beer ME measuring module and an Xsample 520 sample changer (Anton Paar, GmbH, Graz, Austria). RNA was isolated from the samples using a PureLink RNA Mini Kit (ThermoFisher Scientific, Massachusetts, USA) and quantified using a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Massachusetts, USA)Cell counts of L. amylovorus FST2.11 were determined by diluting 1 ml aliquots of BSY in 9ml of strength Ringers’ solution. Samples were serially diluted and 10OpI aliquots were spread-plated onto MRS agar supplemented with 0.05g/L bromocresol green. Plates were incubated anaerobically at 30°C for 48h.
Dried ingredient characterisation
Compositional analysis
Compositional analysis was performed externally by Chelab SRL (Treviso, Italy): Moisture was determined gravimetrically; Protein was determined using the DUMAS method with a nitrogen-protein conversion factor of 6.25; fat was analysed using the Soxhlet method; Fibre was determined using Rapid Total Fibre Determination in accordance with AOAC 2017.16; Ash content was determined
gravimetrically; Carbohydrate was determined by difference and energy values were determined by calculation; Total and free amino acid composition was determined using HPLC/ UV-Vis. Bitterness compounds (iso-alpha acids) were determined according to MEBAK method 2.17.1. RNA was isolated from the samples using a PureLink RNA Mini Kit (ThermoFisher Scientific, Massachusetts, USA) and quantified using a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Massachusetts, USA)
Protein Profile
An Agilent Bioanalyser 2100 Lab-on-a-Chip capillary electrophoresis system ( California, USA) was used to determine the protein profiles of the materials and estimate the molecular weights of each of the protein bands. BSY samples were dispersed in 2% SDS, 2 M thiourea and 6 M urea, to give a protein concentration of 2 %. Dispersions were shaken for 2 h at 22 °C and centrifuged to remove insoluble material. Samples were analysed using an Agilent Protein 80 kit according to the instructions within the ranges of 5-80 kDa.
Aroma Compounds
Gas chromatography/ Olfactometry was completed externally by AromaLab (AromaLAB GmbH, Munich). To prepare sample for GC-O, 15 g of sample as extracted with 100 mL of diethyl ether. The organic layer was separated from the residue and the volatile compounds were isolated via distillation. The sample solution was dried over sodium sulphate and concentrated to 100 pL using a Vigreux column.
Sensory evaluation
The aroma, taste, and flavour characteristics of CBSY and FBSY were determined by a panel of seven experienced panel members. Sample preparation consisted of dissolving the CBSY and FBSY powders in water at a 5 % w/w concentration and labelling each with a three digit code to avoid bias. Characteristics included aroma, taste, flavour and aftertaste descriptors (Aroma; intensity, yeast, cereal/grain, beer, fruity, roasted. Taste; sour, bitter, sweet, umami, salty. Flavour; Intensity,
mushroom, roasted, yeast, beer, cheese, fruity. Aftertaste; intensity). Samples were presented to the panel one at a time and the participants were asked to first rate the intensity of each attribute from 0 to 10 , with 10 being overwhelming and 0 being undetectable. Panellists were provided with water to cleanse the palate between samples, and a reference list defining each of the characteristics of interest was provided
Colour
The colour of the ingredient powders was measured using the Minolta colour measuring system (Chroma meter CR-400/410 Konica Minolta). Colour was measured using the CIE colour system (XYZ values) and then translated into and reported using the hunter colour system (L*a*b*).
Statistical analysis
All fermentations were performed in triplicate, while metabolomic analysis and sensory analysis were completed in duplicate. All were subjected to the independent samples t-test of statistical significance using the IBM SPSS software (IBM SPSS Statistics Ver. 28.0.0.0 (190) using a significance level of 5%. a- 3- and Total Glucans
The 1 ,3:1 ,6-[3-glucan and a-glucan content of the samples was determined using the Yeast and Mushroom [3-glucan assay kit (Megazyme, Bray, Ireland). This method consists of solubilising and hydrolysing all glucans ( 1 ,3:1 ,6-[3-D-Glucans,
1 .3-[3-D-glucans and a-glucans) in highly concentrated sulphuric acid. The remaining glucan fragments are then enzymatically hydrolysed to glucose, using
1 .3-|3- glucanase and [3-glucosidase. Glucose quantification using glucose oxidase/peroxidase (GOPOD) reagent, gives the value for total glucans.
Separately, a-glucans (i.e. phytoglycogen and starch) and sucrose are specifically hydrolysed using amyloglucosidase and invertase. [3-glucan is then determined by difference.
Foaming
Dispersions (20 mL in 50 mL centrifuge tubes) with a concentration of 2% were prepared using distilled water. The pH was adjusted to pH 7 for half of the samples using a variety of HCI and NaOH dilutions. Samples were allowed to hydrate overnight at 4°C. After allowing the samples to return to room temperature, pH was checked and re-adjusted if needed. The samples were then frothed using an llltra- Turrax equipped with a S10N-10G dispersing element (Ika-Labortechnik, Janke and Kunkel GmbH, Staufen, Germany) at maximum speed for 30 s. The height of the foam phase was recorded immediately and after 60 mins. Foaming capacity and foam stability were determined by the following:
Foaming capacity (%) = (Foam height immediately after foaming I Initial sample height) x 100
Foam stability (%) = (Foam height after 1 h I Foam height immediately after foaming) x 100
Water and Oil Absorption
The water and oil binding capacities of the CBSY and PBSY were determined according to the method of (Boye et al., 2010) with some slight modifications. 15 mL tubes were weighed, and the weight noted and then 1 g of sample was weighed into each tube. Then 6 g of either sunflower oil or water was added to the tubes and mixed well, via vortex, for 3 minutes. Samples were then kept at room temperature for 1 hour. Samples were then centrifuged at 4000 x g for 30 minutes at 20°C. Supernatant was removed and samples were inverted and allowed to drain for 30 minutes. The tubes were then re-weighed and the % oil or water absorption was calculated using the following:
WHC/OHC (%)=((Weight of tube and pellet)-(Weight of tube)-(lnitial ingredient weight))/(lnitial ingredient weight) *100
Surface hydrophobicity
Surface hydrophobicity (SO) was measured based on the method of Hayakawa and
Nakai, using 1-anilino-8-naphthalenesulfonate (ANS), with slight modifications as
described by Karaca et al. Protein dispersions of 0.2 % (w/v) protein were prepared in 0.01 M sodium phosphate buffer pH 7 and hydrated over night at 4°C, while shaking. Dilutions were prepared to give 8 ml in 15 mL tube (0.0006, 0.0012, 0.0025, 0.0050, 0.0100, 0.0150 % w/v protein). Following this, 2 mL of each dilution, and sodium phosphate buffer blank, was transferred to new 15 mL tubes and 20 pL of ANS (8.0 mM in 0.1 M phosphate buffer, pH 7) was added to 2 mL of each sample and they were left in darkness for 15 min. Fluorescence was measured (Aexcitation 390 nm, Aemission 470 nm) and adjusted with a blank measured without ANS. The results are presented as the slopes (r2 > 0.98) of the absorbance versus protein concentration.
Protein solubility
Protein solubility, at native and adjusted pH (pH 7) was evaluated using the Kjeldahl method. Firstly, the protein contents of CBSY and PBSY were determined. Following this, 1 % (w/v) protein dispersions were prepared and then left to hydrate over night at 4°C, while shaking. After returning to room temperature, pH was check ad re-adjusted if necessary. Samples were then centrifuged at maximum speed (4892 x g) for 30 mins. The protein content of the supernatant was determined, and protein solubility can be expressed as the % of total protein present in the supernatant.
Emulsion properties
The surface acting properties of CBSY and PBSY were examined by creating and analysing rough emulsions using the method of (Horstmann et al., 2017) with some modifications. A 1 % w/w aqueous protein solution was prepared using CBSY/PBSY and adjusted to pH 7 using NaOH and HCI. Samples were then hydrated overnight, shaking, at 4°C. These solutions were then used to prepare a 10 % w/w sunflower oil/protein solution mixtures where were then homogenised for 2 minutes using an Ultraturrax T10, fitted with S10N - 10G dispersing tool, to create an emulsion. Particle size was then analysed using a Mastersizer 3000 (Malvern Instruments Ltd., Worcestershire, UK), using a refractive index of 1.47.
Emulsion stability was analysed using a LUMisizer (L.U.M. GmbH, Germany), at 100 ref for 15 minutes.
Rheological analysis Rheological tests were carried out using a rheometer (MCR301 , Anton Paar GmbH, Graz, Austria) equipped with a concentric cylinder measuring system (C-CC27- T200/SS, Anton Paar GmbH, Austria). Ingredient dispersions (20 % w/v) were hydrated overnight (16hrs) at 4 °C, while shaking. This concentration was determined by minimum gelling concentration pre-trials (data not shown). Small deformation oscillatory rheology was used to examine heat gelation, using a strain of 0.1 % and a frequency of 1 Hz. The temperature profile was defined as an increase from 20 °C to 90 °C, followed by a hold at 90 °C for 30 minutes, cooling to 20°C, and a hold at 20 °C for 30 minutes. This was followed by a frequency sweep from 0.01 Hz to 10 Hz, while maintaining 1 % strain.
Results
Table 1 Composition of control BSY and processed BSY, as analysed by CheLAB, internally (RNA) and TUM (a-acids):
CBSY PBSY g/100g D.M.
Moisture 6.7 ±0.4 14.5 ±0.38
Proteins 33.2 ± 1.4 (35.6 ± 1.501) 33.1 ± 1.4 (38.7 ± 1.638)
Total Fats 1.0 ±0.079 (1.4 ±0.001)
1.3 ±0.08 (1.4 ±0.089
Total dietary fibre 22.3 ±4.83 (23.9 ±5.177) 21.1 ±5.1 (24.7 ±5.968)
High molecular weight dietary 20.0 ±0.48 (21.4 ±0.515) 21.1 ±5.1 (24.7 ±5.968) fibre
Soluble dietary fibre 2.3 ±0.55 (2.4 ±0.59) <LOQ
Ash 5.3 ± 0.30 (5.6 ±0.322) 2.9 ±0.18 (3.4 ±0.211)
Total Carbohydrates 31.3 ±5.05 (33.5 ±5.416) 27 ±5.306 (31.8 ±6.209)
Energy value (kcal) 314 ± 10 294 ± 10
Energy value (kJ) 1322 ±45 1237 ±47 Dry matter 93.3 ± 0.38 85.5 ± 0.38
Calcium 0.2 ± 0.019 (0.249 ± 0.02) 0.270 ± 0.022 (0.316 ±
0.026)
Iron 0.007 ± 0.001 (0.007 ± 0.007 ± 0.001 (0.008
0.001) ±0.002)
Phosphorus 0.986 ± 0.079 (1.057 0.660 ± 0.053 (0.772 ±
±0.085) 0.062)
Magnesium 0.131 ±0.014 (0.153 ±
0.206 ± 0.023 (0.221 0016)
±0.025
Manganese 0.001 ± 0 (0.001 ± 0)
0.001 ± 0 (0.001 ±0)
Potassium 1.490 ± 0.15 (1.597 0.495 ± 0.048 (0.579 ±
±0.161) 0.056)
Copper 0 ± 0 0 ± 0
Sodium 0.027 ± 0.003 (0.029 0.017 ± 0.002 (0.019 ±
±0.003) 0.002)
Zinc 0.007 ±0.001 (0.008 0.008 ± 0.002 (0.0.009
±0.002) ±0.002)
Total 2.956 (3.168) 1.588 (1.858)
Glucose 0.155 ± 0.013 (0.0166 ± 0 ± 0 (0.00 ± 0.00)
0.014)
Fructose 0.0836 ± 0.009 (0.09 8.48 ± 0.550 (9.924 ±
±0.009) 0.644)
Maltose 0.0421 ± 0.009 (0.045 0.106 ± 0.017 (0.124
±0.01) ±0.02)
Total Sugars 0.2807 ± 0.018 (0.301 8.586 ± 0.550 (10.048
±0.019) ±0.644)
RNA 4.256 ± 0.274 1.118 ± 0.269
IBU mg/ L
Bitterness compounds (iso-a- 129 100 acids)
Table 2: Total Amino Acid Profile of CBSY and PBSY, with results expressed as g/ 100g protein. Additionally, the percentage of essential amino acid requirement met per g protein is shown, as advised by the World Health Organisation (2007). * = Tyrosine is non-e
Essential CBSY % of PBSY % of
Amino Acids g/100 g requirement g/100 g requirement protein protein
Histidine 2.018 ± 0.331 134.5 1.964 ± 0.332 130.9
Isoleucine 3.524 ± 0.572 117.5 4.501 ± 0.695 150.0
Leucine 6.08424 ± 103.1 6.495 ± 0.816 110.1
0.81324
Lysine 7.560 ± 0.904 168.0 8.066 ± 0.967 179.2
Methionine 2.413 109.7 2.251 102.3 and cysteine Methionine 1.295± 0.208 80.9 1.489 ± 0.239 93.1
Cysteine and 1.117 ± 0.181 186.2 0.761 ± 0.124 126.9
Cystine Phenylalanin 6.747 177.5 7.25 190.8 e and tyrosine Phenylalanin 3.795± 0.633 4.0179 ± e 0.665
Tyrosine* 2.952 ± 0.482 3.232 ± 0.514
Threonine 4.428 ± 0.693 192.5 5.136 ± 0.725 223.3
Tryptophan 0.967 ± 0.105 161.1 0.810 ± 0.088 134.9
Valine 4.157 ± 0.663 106.6 5.649 ± 0.755 144.9
Non-essential
Amino Acids
Aspartic acid 9.217 ± 1.054 9.123 ± 1.057
Glutamic acid 14.729 ± 11.057 ±
1.566 1.208
Alanine 6.265 ± 0.813 6.132 ± 0.816
Arginine 6.054 ± 0.783 5.045 ± 0.725
Glycine 4.217 ± 0.663 4.018 ± 0.665
Proline 5.151 ± 0.723 4.803 ± 0.695
Serine 5.572 ± 0.753 5.498 ± 0.755
Total amino 87.017 ± 86.228 ± acids 3.142 3.051
Table 3: Gas Chromatography - Olfactory results; 0= not detected, 1= weakly detected, 2= unequivocally detectable, 3= intensely detectable
Compound Source Odour Flavour Intensity Intensity
-CBSY -PBSY
Ethyl-3- methyl Unknown Fruity, Sweet, 1.75 1.5 butanoate sweet, fruity, apple spicy
2,3,- Yeast/ Buttery/cr Buttery/cre 0.5 1.75 butanedione Bacterial eamy/sw amy/sweet
(diacetyl) fermentation eet
Acetic acid Bacterial Sour, Sour, 1.5 3 fermentation acidic acidic
2-ethyl-3,5/6 - Maillard Earthy/bu Earthy/bur 2 n.d. dimethyl reaction/pyroly mt nt pyrazine sis of serine and threonine Methional Thermal Boiled Boiled 2.75 2.25 induction/ potato, potato,
Maillard vegetabl vegetable reaction e
Butanoic acid Yeast cheesy, Sour, 2 1.5
(butyric acid) fermentation sharp, acidic, acetic cheesy
Phenylacetald Yeast green, honey, 1 2 ehyde fermentation sweet, floral, floral sweet, cocoa 2-/3- methyl Bacterial cheesy, cheesy, 3 2.5 butanoic acid metabolite sour, fruity, tropical fermented
2-acetyl-2- Yeast corn, com, 2
thiazoline fermentation potato, popcorn, toasted roasted, grain
Hexanoic acid Yeast Fatty, Cheesy, 2
metabolite - sour, fruity, formed during cheesy phenolic, butyric acid goat fermentation
Octanoic Acid Yeast fatty, soapy, 2
metabolite waxy, rancid, (under hypoxic cheesy, cheesy, conditions) fatty
4- Bacterial Phenolic, phenolic 1.5
methylphenol metabolite narcissus from amino , animal, acid mimosa breakdown
Sotolon Yeast Caramel- Caramel- 2
metabolism like, like, sweet, sweet, maple maple
Decanoic acid Yeast fatty, soapy, 2.5 2.25 metabolite rancid, waxy, (under hypoxic sour, fruity conditions) citrus phenylacetic Yeast honey, Honey, 2.5 2.25 acid metabolite sweet, sweet, floral floral vanillin Additive, beer vanilla, vanilla, 3 2.25 aging in wood, sweet, sweet, breakdown of creamy creamy phenol compounds during beer storage, wild contaminant yeast phenylpropioni Derived from floral, 2.25 2.5 c acid propionic acid, sweet, conjugate acid fatty of 3- phenylpropion ate
Value CBSY PBSY
L* 78.570 ± 0.240 69.709 ± 0.579 a* 2.479 ± 0.054 5.175 ± 0.111 b* 14.447 ± 0.232 18.347 ± 0.056
Table 5: Alpha-, Beta- and Total glucan values as determined for CBSY and PBSY, expressed as g/100 g dry matter g/100 g DM
Total glucan a-glucan p-glucan
CBSY 39.788 ± 0.443 14.822 ± 0.607 24.966 ± 0.753
PBSY 26.316 ± 0.693 11.319 ± 0.356 14.997 ± 0.379
Table 4 Foaming capacity (%) and foaming stability (%) of CBSY and PBSY after 30 and 60 minutes, at native pH and pH 7.
Native pH pH 7
CBSY PBSY CBSY PBSY
Foaming Capacity (%) 54.768 ± 36.296 32.308 ± 31 .282 ±
2.608 ±1.283 1.538 4.945
Foam stability (30 42.658 ± 0 ± 0.000 0 ± 0.000 69.006 ± mins) (%) 1.205 4.052
Foam stability (60 27.923 ± 0 ± 0.000 0 ± 0.000 57.627 ± mins) (%) 2.885 4.840
Table 5: Oil and Water absorption capacity of CBSY and PBSY, expressed as a percentage of initial sample weight
Fat Absorption Water Holding (%) (%)
CBSY 178.098 ± 1.379 52.704 ± 1.587
PBSY 183.310 ± 3.186 48.701 ± 0.321
Table 8: The surface hydrophobicity, protein solubility (%), and Zeta potential (mV) of CBSY and PBSY, at native pH and pH 7
CBSY PBSY
Surface Hydrophobicity 2906.933 ± 189.867 ±
(mV) 20.387 26.942
Protein Solubility (%) Native 31 .531 ± 0.420 75.426 ± 0.419 pH pH 7 31.508 ± 0.331 72.916 ± 0.174
Zeta potential Native -13.1167 ± 1 .532 -1 .17889 ± 0.301 pH pH 7 -14.1778 ± 1.525 -8.39333 ± 0.284
Summary
Fermentation with BSY significantly increases levels of free amino acids. The level of RNA in the food is decreased. Through processing, the flavour and aroma are transformed from bitter, yeast-like and alcohol-like to a more pleasant fruity, sour and floral profile. The levels of lactic acid and pyruvic acid are increased, and pH is lowered from pH 6 to pH3.5. The colour changed from a pale, creamy beige to a warm, biscuit-like brown. Protein solubility increased significantly. Foaming capacity and stability are improved. Many important functional properties, such as gelling, fat absorption and emulsifying properties are unaffected by the process. The key nutritional profile is unchanged by processing.
Equivalents
The foregoing description details presently preferred embodiments of the present invention. Numerous modifications and variations in practice thereof are expected to occur to those skilled in the art upon consideration of these descriptions. Those
modifications and variations are intended to be encompassed within the claims appended hereto.
Claims
1 . A method of processing spent brewer’s yeast (BSY) to a fermented BSY product comprising the steps of: autolysis of the BSY; and lactic fermentation of the autolysed BSY with a lactic acid bacterium (LAB) to provide a fermented BSY product,
In which the lactic fermentation step comprises incubating in a reactor vessel a fermentation mixture comprising the autolysed BSY and the lactic acid bacterium, in which the fermentation mixture comprises at least 90% autolysed BSY.
2. A method according to Claim 1 in which the fermented BSY product is dried.
3. A method according to Claim 1 or 2, in which a carbon source is added to the autolysed BSY prior to autolysis.
4. A method according to any preceding Claim, in which the LAB is an alcohol tolerant and hop-resistant strain of LAB.
5. A method according to Claim 4, in which the LAB is a strain of Lactobacillus amylovorus.
6. A method according to Claim 5, in which the strain of Lactobacillus amylovorus is Lactobacillus amylovorus FST 2.11 .
7. A method according to any preceding Claim, in which the autolysis step comprises thermal autolysis of the BSY.
8. A method according to Claim 7 in which the thermal autolysis comprises heating the BSY for a time and temperature suitable to degrade yeast RNA and release cell contents, followed by sterilisation to kill any viable yeast cells prior to the fermentation.
9. A method according to Claim, in which the heating step comprises heating the BSY at 40-60°C for 12-48h.
10. A method according to Claim 8 or 9, in which the sterilisation step comprises heating at 80-100°C for 20-40 minutes.
11 . A method according to any preceding Claim, in which prior to the autolysis step the BSY is treated to reduce the alcohol content, optionally by centrifugation.
12. A method according to Claim 11 , in which the solids content of the alcohol depleted BSY is normalised by adding water.
13. A method according to Claim 12, in which the solids content of the BSY is normalised to 20 to 60% (w/v).
14. A method according to Claim 3, in which the carbon source is a simple sugar which is optionally added to the BSY at a concentration of 1-10% (w/w).
15. A method according to any preceding Claim, in which the fermentation mixture comprises autolysed BSY, sugar and lactic acid bacteria.
16. A method according to any preceding Claim, in which the fermentation mixture consists essentially of autolysed BSY, sugar and lactic acid bacteria.
17. A method according to any preceding Claim, in which the fermentation mixture comprises at least 90% (w/v) autolysed BSY, at least 2% (w/v) sugar and lactic acid bacteria.
18. A method according to any preceding Claim, in which the fermentation mixture comprises 90 - 99% (w/v) autolysed BSY, 0 - 9% (w/v) sugar and lactic acid bacteria.
19. An autolysed and lactic acid fermented BSY product characterised by: a bitterness lower than BSY that has not been autolysed and subjected to lactic acid fermentation; a RNA content lower than BSY that has not been autolysed and subjected to lactic acid fermentation; and a protein content that is at least 95% (w/w/) of BSY that has not been autolysed and subjected to lactic acid fermentation.
20. An autolysed and lactic acid fermented BSY product according to Claim 19, having an energy content of at least 250 kCal.
21 . An autolysed and lactic acid fermented BSY product according to Claim 19 or 20, having a free amino acid content of 5 to 15 g/100 g
22. An autolysed and lactic acid fermented BSY product according to Claim 19, having less than 129 IBU mg/ L of bitterness compounds ((iso-a-acids).
23. An autolysed and lactic acid fermented BSY product according to Claim 19, having a RNA content of less than 2%.
24. An autolysed and lactic acid fermented BSY product according to Claim 19, having a protein content of 25 to 40 % (w/w).
25. A method of processing spent brewer’s yeast (BSY) to a fermented BSY product comprising the steps of: autolysis of the BSY; and lactic fermentation of the autolysed BSY with a lactic acid bacterium (LAB) to provide a fermented BSY product,
In which the lactic fermentation step comprises incubating in a reactor vessel a fermentation mixture consisting essentially of the autolysed BSY, sugar and the lactic acid bacterium.
26. A method of processing spent brewer’s yeast (BSY) to a fermented BSY product comprising the steps of: treating BSY to remove alcohol; normalising the solids content of the treated BSY by addition of an aqueous liquid; autolysis of the treated and normalised BSY; and lactic fermentation of the autolysed BSY with a lactic acid bacterium (LAB) to provide a fermented BSY product.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22202223.8 | 2022-10-18 | ||
EP22202223 | 2022-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024083954A1 true WO2024083954A1 (en) | 2024-04-25 |
Family
ID=83903212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2023/079071 WO2024083954A1 (en) | 2022-10-18 | 2023-10-18 | A method of processing spent brewer's yeast |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024083954A1 (en) |
-
2023
- 2023-10-18 WO PCT/EP2023/079071 patent/WO2024083954A1/en unknown
Non-Patent Citations (5)
Title |
---|
CHAMPAGNE CLAUDE P. ET AL: "Effect of the production or use of mixtures of bakers' or brewers' yeast extracts on their ability to promote growth of lactobacilli and pediococci", vol. 6, no. 3, 15 December 2003 (2003-12-15), CL, pages 717 - 3458, XP093030297, ISSN: 0717-3458, Retrieved from the Internet <URL:https://www.scielo.cl/pdf/ejb/v6n3/a04.pdf> DOI: 10.2225/vol6-issue3-fulltext-3 * |
FERREIRA I M P L V O ET AL: "Brewer's Saccharomyces yeast biomass: characteristics and potential applications", TRENDS IN FOOD SCIENCE & TECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, GB, vol. 21, no. 2, 1 February 2010 (2010-02-01), pages 77 - 84, XP026885735, ISSN: 0924-2244, [retrieved on 20091028], DOI: 10.1016/J.TIFS.2009.10.008 * |
JAEGER ALICE ET AL: "Brewer's Spent Yeast (BSY), an Underutilized Brewing By-Product", FERMENTATION, vol. 6, no. 4, 11 December 2020 (2020-12-11), pages 123, XP093030157, DOI: 10.3390/fermentation6040123 * |
RADOSAVLJEVIC MILOS ET AL: "Brewing and malting technology by-products as raw materials in L-(+)-lactic acid fermentation", vol. 95, no. 2, 12 December 2018 (2018-12-12), Hoboken, USA, pages 339 - 347, XP093030529, ISSN: 0268-2575, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jctb.5878> DOI: 10.1002/jctb.5878 * |
RAKIN MARICA ET AL: "The Influence of Brewer's Yeast Autolysate and Lactic Acid Bacteria on the Production of a Functional Food Additive Based on Beetroot Juice Fermentation", vol. 42, no. 2, 1 April 2004 (2004-04-01), Croatia, pages 109 - 113, XP093030923, ISSN: 1330-9862, Retrieved from the Internet <URL:https://hrcak.srce.hr/file/163283> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Behera et al. | Lactobacillus plantarum with functional properties: an approach to increase safety and shelf-life of fermented foods | |
Sanni et al. | Biochemical composition of infant weaning food fabricated from fermented blends of cereal and soybean | |
JP4615820B2 (en) | Method for producing fermented food with high content of γ-aminobutyric acid and free amino acid | |
Nago et al. | Characterization of the Beninese traditional ogi, a fermented maize slurry: physicochemical and microbiological aspects | |
TWI520686B (en) | Method for preparing natural neutral flavor | |
JP2003529383A (en) | Fermented protein hydrolyzate | |
JP5467433B2 (en) | Seaweed fermentation composition and method for producing the same | |
PL186852B1 (en) | Method of preparing a seasoning | |
WO2012011402A1 (en) | Yeast extract containing lactic acid | |
JP2005312438A (en) | FOOD MATERIAL WITH HIGH gamma-AMINOBUTYRIC ACID CONTENT AND METHOD FOR PRODUCING THE SAME | |
JP2004345986A (en) | Fermented material and method for producing the same | |
RU2136179C1 (en) | Method of taste addition preparing | |
CN107904185B (en) | Lactobacillus and application thereof | |
Adeyemo et al. | Reduction of Anti-nutritional factors of sorghum by lactic acid bacteria isolated from Abacha-an African fermented staple | |
Saglam et al. | An investigation for the development of whey-based probiotic beverages | |
WO2024083954A1 (en) | A method of processing spent brewer's yeast | |
Ganguly et al. | Cereal-based fermented foods for enhanced nutritional attributes and better gut health | |
AU660098B2 (en) | A process for the production of a flavouring agent | |
KR101344916B1 (en) | rice doenjang and manufacturing method thereof | |
CN107048089A (en) | A kind of nutrient base material preparation method and application for coming from fermentation thalli | |
Gaglio et al. | Rubus idaeus by-products: Sustainable improvement of the antioxidant value of sourdough bread by a new end-use of exhausted seeds still containing bioactive compounds | |
JP3791681B2 (en) | Beverage containing acetic acid | |
JP2004283109A (en) | Flavor-improving agent for food and beverage | |
Shayo et al. | Assessment of cyanogenic glucoside (cyanide) residues in Mbege: an opaque traditional Tanzanian beer | |
Fadlallah et al. | Effect of fermentation on biochemical characteristics of sorghum flour supplemented with chickpea flour |